Raymond Scott Turner, MD| Memory And Cognitive Disorders Neurology, Neurology | MedStar Health
About me
Raymond Scott Turner, MD, PhD, is professor of neurology and director of the Memory Disorders program at MedStar Georgetown University Medical Center. Before his recruitment to Georgetown in 2008, he was chief of the neurology service at the VA Ann Arbor Healthcare System and associate professor and associate chair in the Department of Neurology, University of Michigan. Dr. Turner earned his medical degree and a PhD in pharmacology from Emory University, Atlanta, and completed his internship, residency and fellowship at the University of Pennsylvania, Philadelphia. He is board certified in psychiatry and neurology.
Dr. Turner has received numerous prestigious awards, including a fellowship from the Howard Hughes Medical Institute and a Paul Beeson Scholarship. He lectures widely, serves as a reviewer for granting agencies and biomedical journals, and has published more than 70 peer-reviewed papers, editorials and book chapters.
At the MedStar Georgetown Memory Disorders Program, Dr. Turner and his team offer diagnostic services as well as clinical care for older individuals with cognitive disorders. The program also offers a range of research opportunities designed to discover more effective prevention and treatment strategies. To do this, the program partners with healthy older volunteers at risk, as well as individuals with mild cognitive impairment or dementia due to Alzheimer's disease. The program's research is increasingly focused on individuals in the earliest disease stage -- when new treatments may be most effective. Dr. Turner encourages anyone interested in learning more to visit the program website: memory.georgetown.edu
Dr. Turner's Philosophy of Care:
Alzheimer's disease and other progressive dementias of aging are devastating for an individual and his or her family. It is important to seek medical evaluation early if you suspect memory problems are developing. A reversible cause of memory loss may be uncovered, and proven treatments with modest benefits for individuals with mild cognitive impairment or dementia due to Alzheimer's disease are available now. Our team of clinicians have the experience and expertise to provide compassionate and knowledgeable care based on the latest research. We also welcome volunteers and their families to learn about research opportunities and consider participating in a study. This is the only way we will make progress on the war against Alzheimer's disease.
Clinical areas of focus
- Alzheimer's Disease
- Aphasia
- Blurred Vision
- Cluster Headache
- Cognitive Impairment
- Concussion
- Confusion
- Dementia
- Depression
- Dizziness
- Encephalitis
- Facial Nerve Palsy And Paresis
- Facial Pain
- Headache
- Lewy Body Dementia
- Memory Disorders
- Migraine
- Myasthenia Gravis
- Neck Pain
- Nerve Block
- Neuralgia
- Neuropathy
- Numbness
- Parkinson's Disease (PD)
- Prion Diseases
- Tension Headache
- Tingling
- Tremor
- Vascular Neurocognitive Disorder
Conditions and procedures
Conditions I treat
- Abnormal Reflexes
- Acute Inflammatory Demyelinating Polyneuropathy
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis
- Anomia
- Anterograde Amnesia
- Aphasia
- Arm Weakness
- Arteriovenous Fistula
- Arteriovenous Malformation (AVM)
- Ataxia
- Autoimmune Encephalitis
- Behavioral Issues In Dementia
- Behcet Syndrome
- Benign Paroxysmal Positional Vertigo
- Blurred Vision
- Carotid Stenosis
- Central Nervous System Lupus
- Cerebellar Ataxia
- Cerebellar Disease
- Cerebral Aneurysm
- Cerebrovascular Accident (CVA)
- Cervical Dystonia
- Cervical Plexopathy
- Charcot Marie Tooth Disease
- Cluster Headache
- CNS Vasculitis
- Cognitive Impairment
- Concussion
- Confusion
- Cranial Nerve Injury
- Creutzfeldt Jakob Syndrome
- Dejerine Sottas Disease
- Dementia
- Dementia Related To Concussion
- Depression
- Diabetic Lumbosacral Radiculoplexus Neuropathy
- Diabetic Neuropathy
- Diplopia
- Dizziness
- Dural Arteriovenous Fistula
- Encephalitis
- Encephalopathies
- Epilepsy
- Executive Function Disorder
- Expressive Language Disorder
- Facial Droop
- Facial Nerve Palsy And Paresis
- Facial Pain
- Facioscapulohumeral Muscular Dystrophy
- Femoral Neuropathy
- Frontotemporal Neurocognitive Disorder
- Guillain Barre Syndrome (GBS)
- Headache
- HIV Associated Neurocognitive Disorder
- HIV Dementia
- HIV Myopathy
- Horner Syndrome
- Inclusion Body Myopathy
- Ischemic Stroke
- Lacunar Stroke
- Leg Weakness
- Lewy Body Dementia
- Lip Droop
- Lobar Atrophy Of Brain
- Major Neurocognitive Disorder
- Medication Overuse Headache
- Memory Disorders
- Migraine
- Mild Cognitive Impairment
- Mild Neurocognitive Disorder
- Movement Diseases And Disorders
- Multifocal Motor Neuropathy
- Multiple Sclerosis
- Muscle Weakness
- Myasthenia Gravis
- Myelitis
- Myoclonic Epilepsy With Ragged Red Fibers
- Neck Pain
- Nerve Root Disorder
- Nervous System Disorders
- Neuralgia
- Neurocognitive Disorder
- Neurodegenerative Diseases
- Neurological Disorders
- Neuromuscular Diseases
- Neuromyelitis Optica (NMO)
- Neuropathy
- Non Ruptured Cerebral Aneurysm
- Normal Pressure Hydrocephalus
- Numbness
- Occipital Neuralgia
- Orthostatic Hypotension
- Paramyotonia Congenita
- Paraplegia
- Paresthesia
- Parkinson's Disease (PD)
- Periodic Paralysis
- Peripheral Nerve Injury
- Peripheral Neuropathy
- Periventricular Leukomalacia
- Plexopathy
- Positional Vertigo
- Post Concussion Syndrome
- Post Traumatic Amnesia
- Primary Cerebellar Degeneration
- Primary Progressive Aphasia
- Prion Diseases
- Pseudobulbar Palsy
- Pseudotumor Cerebri
- Quadriplegia
- Radiculopathy
- Receptive Aphasia
- Semantic Dementia
- Senility
- Sensory Impairment
- Sensory Neuronopathy
- Small Fiber Neuropathy
- Spasticity
- Spinocerebellar Ataxia
- Spinocerebellar Degeneration
- Spinocerebellar Diseases
- Statin Myopathy
- Subarachnoid Hemorrhage
- Syncope
- Tension Headache
- Tetraplegia
- Tic Disorders
- Tingling
- Tinnitus
- Torticollis
- Transient Global Amnesia
- Transient Ischaemic Attack (TIA)
- Transmissible Spongiform Encephalopathies
- Traumatic Brain Injury
- Tremor
- Trigeminal Neuralgia
- Unsteady Gait
- Vascular Neurocognitive Disorder
- Vertigo
- Vision Loss
- Visual Impairment
- Visual Information Processing
Procedures I perform
- Alzheimer's Testing
- Angiography
- Avm Embolization
- Botox For Dystonia
- Botox For Hemifacial Spasm
- Botox For Migraines
- Botox For Spasticity
- Brain Injury Rehabilitation
- Epilepsy Monitoring Unit Evaluation (EMU)
- Headache Therapy
- Multiple Sclerosis (MS) Infusion Treatment
- Nerve Block
- Neurocognitive Testing
- Neurologic Disorder Treatments
Practice locations
Distance from Change LocationEnter your Location
3800 Reservoir Road Northwest Pasquerilla Healthcare Center 7th Fl Dept Neurology Washington, DC, 20007
202-444-8525Fax 202-444-2661
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Aetna Medicare Advantage HMO & PPO Plans
- Innovation Health: Open POS Plus
- Innovation Health: Open POS II
- Aetna Managed Choice Open Access (POS)
- Aetna Choice POS & Choice POS II
- Innovation Health: POS Plus
- Aetna Managed Choice (POS)
- Innovation Health: POS
- Aetna Open HMO/Open HMO Option/Open EPO Plus
- Aetna HMO-Open Access/Select OA
- Aetna HealthFund/Health Network Option OA
- Innovation Health: HMO & EPO Plus
- Aetna Select HMO/HealthFund/Health Network
- Aetna HMO
- Innovation Health: Open Network Only Plus
- Aetna Elect Choice/ Open Access (POS)
- Innovation Health: Network Only Plus
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Employee Health Plan (EHP)
- Cigna TotalCare (HMO D-SNP)
- Cigna Preferred Medicare
- Cigna Alliance Medicare (HMO) |
- Cigna Achieve Medicare (HMO C-SNP)
- Veterans Affairs Community Care Network (VA CCN)
- United Medicare Advantage DSNP District of Columbia
- United Student Resources
- United Select Plus (POS)
- United Select HMO - EPO/NPP
- United Options (PPO) (includes Empire PPO)
- United Golden Rule
- United GEHA (for all other states) Compass Rose
- D-SNP)
- I-SNP
- United Nursing Home Plan (C-SNP
- United Erickson Advantage Plans
- United Choice Plus
- United Choice
- United Mamsi Life & Health
- United Core Essential (HMO)
- United Navigate
- MedStar Family Choice DC Healthy Families
- MedStar Family Choice DC Healthcare Alliance
- United MD IPA Preferred (POS)
- United MD IPA (HMO)
- Kaiser Permanente Signature-Added Choice
- Kaiser Signature
- Kaiser HMO Plus and DHMO Plus Member
- Kaiser Select-Added Choice
- Kaiser Select
- Kaiser Medicare Plus
- Kaiser Medicare Advantage Signature and Select
- Kaiser Flexible Choice
- HumanaChoice PPO
- HumanaChoice Honor’s plan PPO
- Health Services for Children with Special Needs (HSCSN)
- Cigna True Choice Plus Medicare (PPO)
- Cigna True Choice Medicare (PPO)
- Cigna POS/Network POS
- Cigna Indemnity
- Cigna POS Open Access & Open Access Plus
- Cigna Network Open Access
- Cigna HMO Open Access
- Cigna PPO and PPO Plus
- Cigna EPO
- Cigna Choice Fund PPO
- Beech Street PPO
- Innovation Health: Indemnity
- Aetna Traditional Choice (PPO)
- Aetna Student Health Insurance
- Aetna Signature Administrator PPO/TPA
- Aetna Quality Point of Service (POS)
- Innovation Health: PPO
- Aetna Open Choice (PPO)
- Cigna HMO & Network (HMO)
- WellPoint Maryland - Maryland Health Choice
- WellPoint Maryland
- Virginia Premier
- Veterans Affairs Community Care Network
- UnitedHealthcare Individual Exchange Plans
- United Community Plan - Maryland Health Choice Program
- Uniformed Services Family Health Plan (USFHP)
- Private Health Care Systems (PHCS) (PPO)
- Priority Partners - Maryland Health Choice
- Police and Fire Clinic
- United Optimum Choice Preferred (POS) & OCI Direct (HMO)
- United Optimum Choice
- United Group Medicare Advantage Plans
- United AARP Medicare Complete
- Traditional Medicare Fee for Service
- Medicaid - Virginia
- Medicaid - Maryland
- Medicaid - District of Columbia
- Tricare for Life East
- Tricare Reserve Select
- Tricare East Select
- Tricare East Prime
- Maryland Point of Service Plan (MPOS)
- HealthyBlue PPO
- Federal Employee Program (Std/Basic PPO/Blue Focus)
- CareFirst NASCO
- CareFirst MedStar Select PPO
- CareFirst MedStar PPO
- CareFirst Maryland Indemnity or PPO
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- CareFirst Group Medicare Advantage
- CareFirst BC/BS Advantage Core/Enhanced
- CareFirst Blue Card Program (Out-of-area BCBS plans)
- CareFirst Administrators
- CareFirst (NCA) Indemnity
- Carefirst BlueChoice Opt Out Plus Open Access (POS)
- Carefirst Healthy Blue (HMO/POS)
- Carefirst BlueChoice Opt Out Open Access
- Carefirst BlueChoice Open Access
- Carefirst BlueChoice HMO
- Carefirst EPO
- Carefirst Blue Preferred PPO
- Coventry Health Care National Network PPO
- MedStar Family Choice - Maryland Health Choice
- First Health PPO
- Coventry of Delaware HMO/PPO
- Coventry Health Care of Virginia
- Great-West Healthcare POS/CIGNA
Education
Fellowship: Hospital of the University of Pennsylvania (1995)
Residency: Hospital of the University of Pennsylvania (1992)
Internship: University of Pennsylvania School of Medicine GME (1989)
Medical School: Emory University School of Medicine (1988)
Awards
- Paul Beeson Career Development Award in Aging Research American Federation for Aging Research, Postdoctoral Research Fellowship for Physician-Scientists Howard Hughes Medical Institute Alzheimer's Association Honoree, Washington Monuments, National Capital Area Chapter, Alzheimer's Association
Hospital affiliations
News and publications
- Diaz-Asper C, Chandler C, Turner RS, Reynolds B, Elvevåg B: Increasing access to cognitive screening in the elderly: applying natural language processing methods to speech collected over the telephone. Cortex. 2022 Nov;156:26-38. doi: 10.1016/j.cortex.2022.08.005. Epub 2022 Aug 30. PMID: 36179481
- Greco GA, Rock M, Amontree M, Lanfranco MF, Korthas H, Hong SH, Turner RS, Rebeck GW, Conant K: CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice. Neurobiol Dis. 2023 Apr;179:106057. doi: 10.1016/j.nbd.2023.106057. Epub 2023 Mar 5. PMID 36878326
- Stevenson M, Varghese R, Hebron ML, Liu X, Ratliff N, Smith A, Turner RS, Moussa C: Inhibition of discoidin domain receptor (DDR)-1 with nilotinib induces autophagy and reduces inflammation and vascular fibrosis in Alzheimer’s disease. J Neuroinflammation. 2023 May 16;20(1):116. doi: 10.1186/s12974-023-02802-0. PMID: 37194065
- Bushnell J, Hammers DB, Aisen P, Dage JL, Eloyan A, Foroud T, Grinberg LT, Iaccarino L, Jack CR Jr, Kirby K, Kramer J, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Nudelman K, Rumbaugh M, Soleimani-Meigooni DN, Toga A, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG, Clark DG; LEADS Consortium. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13434. Online ahead of print. PMID: 37653686
- Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack Jr. CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici G. Amyloid and tau-PET in early-onset AD: baseline data from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS). Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13453. Online ahead of print. PMID: 3769010
- Dage JL, Eloyan A, Thangarajah M, Hammers DB, Fagan AM, Gray JD, Schindler SE, Snoddy C, Nudelman K, Faber KM, Foroud T, Aisen P, Ghetti B, Griffin P, Grinberg LT, Jack Jr CR, Kirby K, Kramer J, Koeppe R, Kukull WA, Murray ME, Rumbaugh M, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova L: Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer’s Disease Study. Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13399. Online ahead of print. PMID: 37491668
- Eloyan A, An N, Thangarajah M, Dage JL, Fagan AM, Foroud T, Aisen P, Ghetti B, Griffin P, Grinberg LT, Jack Jr CR, Kirby K, Kramer J, Koeppe R, Kukull WA, Murray ME, Rumbaugh M, Toga A, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Beckett L, Gao S, Carrillo MC, Rabinovici G, Apostolova LG, Dickerson B, Vemuri P: White matter hyperintensities are higher among early-onset Alzheimer’s disease participants than their cognitively normal and early-onset nonAD peers: LEADS Study. Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13402. Online ahead of print. PMID: 37491599
- Hammers DB, Nemes S, Diedrich T, Eloyan A, Kirby K, Aisen P, Kramer J, Nudelman K, Foroud T, Rumbaugh M, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Weintraub S, Wingo TS, Wolk DA, Wong B, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium. Learning slopes in early-onset Alzheimer’s disease. Alzheimers Dement 2023 May 27. doi: 10.1002/alz.13159. Online ahead of print. PMID: 37243937
- Hammers DB, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S, Kirby K, Aisen P, Dage JL, Foroud T, Griffin P, Grinberg LT, Jack CR Jr, Kramer J, Koeppe R, Kukull WA, Mundada NS, La Joie R, Soleimani-Meigooni DN, Iaccarino L, Murray ME, Nudelman K, Polsinelli AJ, Rumbaugh M, Toga A, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium.Profiling baseline performance on the longitudinal early-onset Alzheimer’s disease study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement 2023 May 31. doi: 10.1002/alz.13160. Online ahead of print. PMID: 37256497
- Nemes S, Logan PE, Manchella M, Mundada NS, La Joie R, Polsinelli AJ, Hammers DB, Koeppe RA, Foroud TM, Nudelman KN, Eloyan A, Iaccarino L, Dorsant-Ardon V, Taurone A, Thangarajah M, Aisen P, Grinberg LT, Jack Jr. CR, Kramer J, Kukull WA, murray ME, Rumbagh M, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Rabinovici GD, Carrillo MC, Dickerson BC, Apostolova LG. Sex and APOE-e4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer’s disease. Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13403. Online ahead of print. PMID: 37496307
- Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, Snoddy C, Faber KM, Foroud T, Hammers DB, DIAN/DIAN-TU Clinical/Genetics Committee, Taurone A, Aisen P, Grinberg LT, Jack Jr CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova L. Pathogenic variants in the longitudinal early-onset Alzheimer’s disease study cohort. Alzheimers Dementia, 2023 Oct 6. doi: 10.1002/alz.13482. Online ahead of print. PMID: 37801072
- Polsinelli AJ, Wonderlin RJ, Hammers DB, Garcia AP, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S, Wang S, Kirby K, Logan PE, Aisen P, Dage JL, Foroud T, Griffin P, Iaccarino L, Kramer JH, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Nudelman K, Soleimani-Meigooni DN, Rumbaugh M, Toga AW, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG, LEADS Consortium. Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) Cohort. Alzheimers Dement 2023 Jun 9. doi: 10.1002/alz.13344. Online ahead of print. PMID: 37296082
- Touroutoglou A, Katsumi Y, Brickhouse M, Aisen P, Beckett L, Dage JL, Eloyan A, Fagan A, Foroud T, Ghetti B, Griffin P, Grinberg LT, Jack Jr. CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Posinelli A, Rumbaugh M, Toga A, Vemuri P, Altri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Rabinovici GD, Apostolova LG, Dickerson BC. The sporadic early-onset Alzheimer’s disease signature of atrophy: Preliminary findings from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) cohort. Alzheimers Dement 2023 Oct 18. doi: 10.1002/alz.13466. Online ahead of print. PMID: 37850549
- Clark DG, Bushnell J, Hammers DB, Aisen P, Dage J, Eloyan A, Foroud T, Grinberg L, Iaccarino L, Jack C, Kirby K, Kramer J, Koeppe R, Kukull W, La Joie R, Mundada N, Murray M, Nudelman K, Rumbaugh M, Soleimani-Meigooni D, Toga A, Touroutoglou A, Vemuri P, Atri A, Day G, Duara R, Graff-Radford N, Honig L, Jones D, Masdeu J, Mendez M, Musiek E, Onyike C, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo T, Wolk D, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer’s disease. Alzheimers Dement, in press, 2023
- Monane M, Johnson KG, Snider BJ, Turner RS, Drake JD, Maraganore DM, Bicksel JL, Jacobs DH, Ortega JL, Henderson J, Jiang Y, Huang S, Coppinger J, Fogelman I, West T, Braunstein JB: A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment. Ann Clin Transl Neurol. 2023 Oct;10(10):1738-1748. doi: 10.1002/acn3.51863. Epub 2023 Aug 7. PMID: 37550958
- Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler-Klein M, Fox NC, Cumming JL, Fontoura P, Doody RS: Two phase 3 trials of gantenerumab in early Alzheimer’s disease. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. PMID: 37966285
- Riviere M-E, Langbaum JB, Turner RS, Rinne JO, Sui Y, Cazorla P, Ricart J, Meneses K, Caputo A, Tariot PN, Reiman EM, Graf A: Active immunotherapy CAD106 in Alzheimer’s disease: effect on amyloid deposition in cognitively unimpaired ApoE4 homozygotes. Alzheimers Dement. 2023 Dec 25. doi: 10.1002/alz.13532. Online ahead of print. PMID: 38145469
- Chandler C, Diaz-Asper C, Turner RS, Reynolds B, Elvevåg B: An explainable learning model of cognitive decline derived from acoustic and linguistic speech features. Alzheimers Dement (Amst). 2023 Dec 27;15(4):e12516. doi: 10.1002/dad2.12516. eCollection 2023 Oct-Dec. PMID: 38155915
- Amontree M, Nelson M, Stefansson L, Pak D, Maguire-Zeiss K, Turner RS, Conant K. Resveratrol differentially affects MMP release from neurons and glia: Implications for therapeutic efficacy. J Neurochem. 2024 Jan 1. doi: 10.1111/jnc.16031. Online ahead of print. PMID: 38163875
- Feldman HH, Messer K, Qui Y, Sabbagh M, Galasko D, Turner RS, Lopez O, Smith A, Durant J, Lupo J-L, Revta C, Balasubramanian A, Kuehn-Wache K, Wassmann T, Schell-Mader S, Jacobs DM, Salmon DP, Leger G, Weber F, for the ADCS VIVA-MIND Study Group. Varoglutamstat: Inhibiting glutaminyl cyclase as a novel target of therapy in early Alzheimer’s disease. J Alzheimers Disease, in press, 2024